Schizophrenia & Psychotic Disorders

When assessing the value of a reward, people with schizophrenia have difficulty integrating information about the size of the reward and the probability of receiving it, according to a published study.

Articles

NEW YORK—An imaging genetics study of brain structure in adolescents suggests that a missense mutation in the zinc-transporter gene SLC39A8, implicated in schizophrenia, affects gray matter volume in the putamen, according to a multinational group of researchers.

Even in a first episode of psychosis (FEP), alterations in brain metabolite levels are associated with neurocognitive performance, according to findings from a 7-Tesla proton magnetic resonance spectroscopy (MRS) study.

People with schizophrenia had increased levels of antibodies against the Epstein-Barr virus, the herpes virus behind infectious mononucleosis, in a study published online in Schizophrenia Bulletin.

The US Food and Drug Administration (FDA) recently published a final order that requires manufacturers to file a premarket approval application for most uses of electroconvulsive therapy (ECT) devices.

People with schizophrenia may experience emotions in their bodies differently than people without the disorder, according to a recent study published online in Schizophrenia Bulletin.

Pages

Blogs

Generic medications may potentially offer significant savings for patients. However, it's important to understand how these medications are similar and different from brand-name medications.

Question:

"Is schizophrenia really a valid diagnostic entity?"

Question:

"In view of the specific structural and neuroendocrine changes now known to occur in schizophrenia, is there any role for therapy—such as cognitive therapy or cognitive enhancement therapy?"

Pages

Posters

Rikinkumar Patel, MD, MPH; Mandeep Kaur, MD; Ahmed Elmaadawi, MD; Zeeshan Mansuri, MD, MPH; Kaushal Shah, MBBS, MPH; Suhayl Nasr, MD
Jason Shafrin, PhD; Katalin Bognar, PhD; Katie Everson, MS; Michelle Brauer, BS; Darius Lakdawalla, PhD; Felicia Forma, BSc
Abigail Nash, MD, PhD; Ibrahim Turkoz, PhD; Adam Savitz, MD, PhD; Maju Mathews, MD; Edward Kim, MD, MBA
Karen Anderson, MD; Mat Davis, PhD; Stewart Factor, DO; Robert Hauser, MD, MBA; Lars Jarskog, MD; Joohi Jimenez-Shahed, MD; Rajeev Kumar, MD, FRCPC; Stanislaw Ochudlo, MD, PhD; William Ondo, MD; Hubert Fernandez, MD

Pages

Video

Leslie Citrome, MD, MPH, discusses the link between schizophrenia and diabetes, the role of metabolic syndrome, weight gain from antipsychotics, and interventions for patients with schizophrenia.

Schizophrenia long-acting injectables

This video is a component of an accredited CME session presented at Elevate by Psych Congress 2017.

The educational activity is supported by educational grants from Alkermes, Inc. and Otsuka America Pharmaceuticals, Inc.

Long-acting injectables schizophrenia

This video is a component of an accredited CME session presented at Elevate by Psych Congress 2017.

The educational activity is supported by educational grants from Alkermes, Inc. and Otsuka America Pharmaceuticals, Inc.

Pages

Audio

Why do so many antipsychotic medications induce symptoms, signs, and physiologic changes that are already present to a lesser degree in the disease states that they are intended to treat?

Pages